Overview

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant CV-metabolic-renal endpoints.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Allopurinol
Anti-Inflammatory Agents